Research Article

PRIMARY FEMUR NEUROBLASTOMA IN A 16-YEAR-OLD: A CASE REPORT

Adewumi O. Alabi1*, Bright A. Igbinoba2, Olusola K. Idowu3, Kolawole O. Aramide2, Nnamdi Orah4, Mohammed Y.M. Habeebu1, Opeyemi I. Olusunmade5, Emmanuel E. Ojiebun6
1 Department of Radiation Biology, Radiotherapy & Radiodiagnosis, College of Medicine, University of Lagos, Lagos.
2 Oncology Unit, National Orthopaedic Hospital, Igbobi, Lagos.
3 University College Hospital
4 Department of Anatomic and Molecular Pathology, College of Medicine, University of Lagos, Lagos.
5 Oncology Unit, National Orthopaedic Hospital, Igbobi, Lagos
6 NSIA-LUTH Cancer Centre, Lagos University Teaching Hospital, Idi Araba, Lagos
* Corresponding author: adewumialabi@gmail.com
Published: Jul, 2025
DOI: 10.67579/njo.2025.jsg8ad20
Pages: 321-327
Views: 265
Downloads: 153

Abstract

The incidence of neuroblastomas in individuals aged 10 and above is less than 10%. It is also associated with poor prognosis in older children and adults. This is a case report of a 16-year-old lady with pain and swelling in the left knee. The definitive diagnosis was neuroblastoma in the left distal femur after immunohistochemistry. The patient underwent surgery and chemotherapy. Extremity neuroblastoma, although rare, can occur even in long bones. High index of suspicion, early detection, appropriate surgical intervention, and chemotherapy can improve the prognosis. This report boosts the currently sparse literature on neuroblastomas in adolescents, especially with skeletal tissues as a primary site of lesion.

Keywords

Neuroblastoma adolescent femur treatment

References

  1. Mahapatra S, Challagundla KB. Neuroblastoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Aug 30]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK448111/
  2. Yan P, Qi F, Bian L, Xu Y, Zhou J, Hu J, et al. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study. Med Sci Monit. 2020 Nov 29;26: e927218. doi: 10.12659/MSM.927218. PMID: 33249420; PMCID: PMC7711874.
  3. Colon NC, Chung DH. Neuroblastoma. Adv Pediatr. 2011;58(1):297–311.
  4. Neuroblastoma in adolescents: Incidence and survival analysis based on SEER data - Esiashvili - 2007 - Pediatric Blood & Cancer - Wiley Online Library [Internet]. [cited 2022 Aug 30]. Available from: https://onlinelibrary.wiley.com/doi/10.1002/pbc.20859
  5. Tan YB, Li JF, Li WS, Yang RL. Primary thoracic neuroblastoma in an adult: A rare case report. Medicine (Baltimore). 2019 Jul;98(30): e16564.
  6. Podda MG, Luksch R, Polastri D, Gandola L, Piva L, Collini P, et al. Neuroblastoma in patients over 12 years old: a 20-year experience at the Istituto Nazionale Tumori of Milan. Tumori. 2010 Sep-Oct;96(5):684-9. doi: 10.1177/030089161009600507. PMID: 21302612.
  7. Gaspar N, Hartmann O, Munzer C, Bergeron C, Millot F, Cousin-Lafay L, et al. Neuroblastoma in adolescents. Cancer. 2003 Jul 15;98(2):349-55. doi: 10.1002/cncr.11521. PMID: 12872356.
  8. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL, Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma. 2014; 2014:375151.
  9. Huang C, Jiang S, Liao X, Li Y, Li S, Yang J. Bone and bone marrow involvement in neuroblastoma: a case report. Medicine (Baltimore). 2020 Oct 2;99(40): e22505. doi: 10.1097/MD.0000000000022505. PMID: 33019449; PMCID: PMC7535680.
  10. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report. J Clin Oncol. 2009 Jan 10;27(2):298–303.
  11. Peters M. Integrating multimodal therapy for optimized cancer treatment: A comprehensive review. J Med Oncl Ther. 2024;9(6):231. 1 J Med Oncl Ther 2024 Volume 9 Issue 6.
  12. Zhao Q, Liu Y, Zhang Y, Meng L, Wei J, Wang B, et al. Role and toxicity of radiation therapy in neuroblastoma patients: A literature review. Crit Rev Oncol Hematol. 2020 May; 149:102924. doi: 10.1016/j.critrevonc.2020.102924. Epub 2020 Mar 3. PMID: 32172225.
  13. Yalçin B, Kremer LC, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301. doi: 10.1002/14651858.CD006301.pub3. Update in: Cochrane Database Syst Rev.
How to Cite

Alabi, A. O., Igbinoba, B. A., Idowu, O. K., Aramide, K. O., Orah, N., Habeebu, M. Y., Olusunmade, O. I., & Ojiebun, E. E. (2025). PRIMARY FEMUR NEUROBLASTOMA IN A 16-YEAR-OLD: A CASE REPORT. Nigerian Journal of Oncology, 1(2), 321-327. https://doi.org/10.67579/njo.2025.jsg8ad20

A. O. Alabi, B. A. Igbinoba, O. K. Idowu, K. O. Aramide, N. Orah, M. Y. Habeebu, O. I. Olusunmade, and E. E. Ojiebun, "PRIMARY FEMUR NEUROBLASTOMA IN A 16-YEAR-OLD: A CASE REPORT," Nigerian Journal of Oncology, vol. 1, no. 2, pp. 321-327, July 2025. doi: 10.67579/njo.2025.jsg8ad20

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles